---
title: "Research Protocol"
subtitle: "Title of study goes here"
author: "Version 1"
date: "`r format(Sys.time(), '%d %B, %Y')`"
output:
  html_document:
    toc: true
    toc_float: true
    number_sections: true
---

```{r include=FALSE}
devtools::install_github("ropenscilabs/icon")
```

&nbsp;
<p style="text-align: left;"><span style="color: #808080;">This protocol contains all elements from the  <a href="http://www.spirit-statement.org/">SPIRIT</a> statement</p>
&nbsp;


|                               	|                       	|
|-------------------------------	|-----------------------	|
| Study Principal Investigator: 	| **Name** Affiliation  	|
| Sponsors:                     	| [enter details]       	|
| Protocol contributors:        	| **Name**  Affiliation 	|
| Trial identifiers:            	|                       	|
<br><br>
**ABBREVIATIONS**

| Abbreviation 	| Explanation                              	|
|--------------	|------------------------------------------	|
| PHI          	| Personal Health Information              	|
| PI           	| Principal Investigator                   	|
| PICF         	| Participant Information and Consent Form 	|
| RA           	| Research Assistant                       	|
| REB          	| Research Ethics Board                    	|



<br><br>

**REVISION HISTORY**


| Version  	| Date       	| Amendment Text 	| Description 	|
|----------	|------------	|----------------	|-------------	|
| 1        	| enter date 	|                	|             	|


<br><br>

# TRIAL SUMMARY

|                                               	| World Health Organization Registration Data Set           	|
|-------------------------------------------------|-------------------------------------------------------------|
| Title                                         	| [enter title]                                             	|
| Primary registry and trial identifying number 	| [enter details]                                           	|
| Secondary identifying numbers                 	| [enter details]                                           	|
| Sources of monetary or material support       	| [enter details]                                            	|
| Primary sponsor contact information           	| [enter details]                                           	|
| Secondary sponsors (if any)                   	| [enter details]                                           	|
| Central contact                               	| [name, affiliation and contact details]                   	|
| Study officials/Investigators                 	| [name and role - PI for example]                          	|
| Brief title                                   	| [enter details]                                           	|
| Acronym                                       	| [enter details]                                            	|
| Countries of recruitment                      	| [enter details]                                           	|
| Condition(s) or focus of study                	| [enter details]                                            	|
| Interventions                                 	|                                                           	|
| *Intervention*                                	| [enter details]                                           	|
| *Standard Care*                               	| [enter details]                                            	|
| Key eligibility criteria                      	| Age eligibility: [N/A or "number years"]<br><br>Sex eligibility: Both<br><br>Accepts healthy volunteers: No <br><br>Inclusion criteria: <br>[Enter details] <br><br>Exclusion criteria:<br>1[Enter details]|
| Study design                                  	| Study type: Interventional trial; Allocation: [Randomized, Non-randomized],Intervention model: [Single group, Parallel, Crossover, Factorial, Sequential],Primary purpose: [Treatment, Prevention, Diagnostic, Supportive Care, Screening, Health Services Research, Basic Science, Device Feasibility, Other],Phase: [Early Phase 1] 	        |
| Masking                                       	| [Participan, Care Provider, Investigator, Outcomes Assessor, None (Open Label)]|
| Date of enrollment                            	| [enter details]                                           	|
| Target sample size                            	| [enter details]                                           	|
| Recruitment status                            	| [Not yet recruiting]                                      	|
| Primary outcomes                              	| Outcome:[enter details]Timeframe: [enter details]Description: [enter details]|
| Secondary outcomes                            	| Outcome: [enter details]Timeframe: [enter details]Description:[enter details]|


---------------------------------
<br>

# INTRODUCTION

## Background and rationale <font size="3">^[`r icon::fa_question_circle(size=0.1)`](http://www.spirit-statement.org/background-and-rationale/)^ </font>



## Objectives <font size="3">^[`r icon::fa_question_circle(size=0.1)`](http://www.spirit-statement.org/objectives/)^ </font>



## Trial design 





# METHODS

## Study setting <font size="3">^[`r icon::fa_question_circle(size=0.1)`](http://www.spirit-statement.org/study-setting/)^ </font>



## Eligibility criteria <font size="3">^[`r icon::fa_question_circle(size=0.1)`](http://www.spirit-statement.org/eligibility-criteria/)^ </font>

### Inclusion criteria 


### Exclusion criteria


## Interventions <font size="3">^[`r icon::fa_question_circle(size=0.1)`](http://www.spirit-statement.org/interventions/)^ </font>

### Intervention description



>Intervention



>Comparison




### Modifications <font size="3">^[`r icon::fa_question_circle(size=0.1)`](http://www.spirit-statement.org/modifications/)^ </font>





### Adherence <font size="3">^[`r icon::fa_question_circle(size=0.1)`](http://www.spirit-statement.org/adherence/)^ </font>




### Concomitant care <font size="3">^[`r icon::fa_question_circle(size=0.1)`](http://www.spirit-statement.org/concomitant-care/)^ </font>



## Outcomes <font size="3">^[`r icon::fa_question_circle(size=0.1)`](http://www.spirit-statement.org/outcomes-2/)^ </font>



>Primary outcome: 



>Secondary outcomes




## Participant timeline <font size="3">^[`r icon::fa_question_circle(size=0.1)`](http://www.spirit-statement.org/participant-timeline/)^ </font>





| STUDY PERIOD                	|           	|            	|                 	|    	|    	|    	|      	|           	|
|-----------------------------	|:---------:	|:----------:	|:---------------:	|:--:	|:--:	|:--:	|:----:	|:---------:	|
|                             	| Enrolment 	| Allocation 	| Post-allocation 	|    	|    	|    	|      	| Close-out 	|
| TIMEPOINT**                 	|     0     	|      0     	|        t1       	| t2 	| t3 	| t4 	| etc. 	|     tx    	|
| ENROLMENT:                  	|           	|            	|                 	|    	|    	|    	|      	|           	|
| Eligibility screen          	|     X     	|            	|                 	|    	|    	|    	|      	|           	|
| Informed consent            	|     X     	|            	|                 	|    	|    	|    	|      	|           	|
| [List other procedures]     	|     X     	|            	|                 	|    	|    	|    	|      	|           	|
| Allocation                  	|           	|      X     	|                 	|    	|    	|    	|      	|           	|
| INTERVENTIONS:              	|           	|            	|                 	|    	|    	|    	|      	|           	|
| [Intervention A]            	|           	|            	|                 	|    	|    	|    	|      	|           	|
| [Intervention B]            	|           	|            	|        X        	|    	|  X 	|    	|      	|           	|
| [List other study groups]   	|           	|            	|                 	|    	|    	|    	|      	|           	|
| ASSESSMENTS:                	|           	|            	|                 	|    	|    	|    	|      	|           	|
| [List baseline variables]   	|     X     	|      X     	|                 	|    	|    	|    	|      	|           	|
| [List outcome variables]    	|           	|            	|                 	|  X 	|    	|  X 	| etc. 	|     X     	|
| [List other data variables] 	|           	|            	|        X        	|  X 	|  X 	|  X 	| etc. 	|     X     	|



## Sample size <font size="3">^[`r icon::fa_question_circle(size=0.1)`](http://www.spirit-statement.org/sample-size/)^ </font>



## Recruitment <font size="3">^[`r icon::fa_question_circle(size=0.1)`](http://www.spirit-statement.org/recruitment/)^ </font>



## Allocation

### Sequence generation <font size="3">^[`r icon::fa_question_circle(size=0.1)`](http://www.spirit-statement.org/sequence-generation/)^ </font>


### Concealment mechanism <font size="3">^[`r icon::fa_question_circle(size=0.1)`](http://www.spirit-statement.org/concealment-mechaninism/)^ </font>


### Implementation <font size="3">^[`r icon::fa_question_circle(size=0.1)`](http://www.spirit-statement.org/implementation/)^ </font>

## Blinding (masking)

### Blinding mechanism <font size="3">^[`r icon::fa_question_circle(size=0.1)`](http://www.spirit-statement.org/blinding-masking/)^ </font>



### Emergency unblinding <font size="3">^[`r icon::fa_question_circle(size=0.1)`](http://www.spirit-statement.org/emergency-unblinding/)^ </font>


## Data collection <font size="3">^[`r icon::fa_question_circle(size=0.1)`](http://www.spirit-statement.org/data-collection-methods/)^ </font>

### Trial procedures and evaluations



### Retention <font size="3">^[`r icon::fa_question_circle(size=0.1)`](http://www.spirit-statement.org/retention/)^ </font>


## Data management <font size="3">^[`r icon::fa_question_circle(size=0.1)`](http://www.spirit-statement.org/data-management/)^ </font>

**Data Forms and Data Entry**




**Data Transmission and Editing**




**Security and Back-Up of Data**




**Study status reports**



## Statistical methods

### Outcomes <font size="3">^[`r icon::fa_question_circle(size=0.1)`](http://www.spirit-statement.org/outcomes/)^ </font>


### Additional analyses <font size="3">^[`r icon::fa_question_circle(size=0.1)`](http://www.spirit-statement.org/additional-analyses/)^ </font>



### Analysis population and missing data <font size="3">^[`r icon::fa_question_circle(size=0.1)`](http://www.spirit-statement.org/objectives/)^ </font>


## Data monitoring

### Formal committee <font size="3">^[`r icon::fa_question_circle(size=0.1)`](http://www.spirit-statement.org/formal-committee/)^ </font>


### Interim analysis <font size="3">^[`r icon::fa_question_circle(size=0.1)`](http://www.spirit-statement.org/interim-analysis/)^ </font>


## Safety/harms <font size="3">^[`r icon::fa_question_circle(size=0.1)`](http://www.spirit-statement.org/harms/)^ </font>



## Auditing <font size="3">^[`r icon::fa_question_circle(size=0.1)`](http://www.spirit-statement.org/auditing/)^ </font>






# ETHICS AND DISSEMINATION

## Research ethics approval <font size="3">^[`r icon::fa_question_circle(size=0.1)`](http://www.spirit-statement.org/research-ethics-approval/)^ </font>




## Protocol amendments <font size="3">^[`r icon::fa_question_circle(size=0.1)`](http://www.spirit-statement.org/protocol-amendments/)^ </font>




## Informed consent process <font size="3">^[`r icon::fa_question_circle(size=0.1)`](http://www.spirit-statement.org/consent-or-assent/)^ </font>



### Ancillary studies <font size="3">^[`r icon::fa_question_circle(size=0.1)`](http://www.spirit-statement.org/ancillary-studies/)^ </font>



## Confidentiality <font size="3">^[`r icon::fa_question_circle(size=0.1)`](http://www.spirit-statement.org/confidentiality/)^ </font>





## Declaration of interests <font size="3">^[`r icon::fa_question_circle(size=0.1)`](http://www.spirit-statement.org/declaration-of-interests/)^ </font>



## Access to data <font size="3">^[`r icon::fa_question_circle(size=0.1)`](http://www.spirit-statement.org/access-to-data/)^ </font>


## Ancillary and post-trial care <font size="3">^[`r icon::fa_question_circle(size=0.1)`](http://www.spirit-statement.org/ancillary-and-post-trial-care/)^ </font>





## Dissemination policy 

### Trial results <font size="3">^[`r icon::fa_question_circle(size=0.1)`](http://www.spirit-statement.org/31a-trial-results/)^ </font>


### Authorship <font size="3">^[`r icon::fa_question_circle(size=0.1)`](http://www.spirit-statement.org/31b-authorship/)^ </font>



### Reproducible research <font size="3">^[`r icon::fa_question_circle(size=0.1)`](http://www.spirit-statement.org/31c-reproducible-research/)^ </font>





# STUDY ADMINISTRATION

## Key contacts

**Study Principal Investigator**



**Central contact**



**Sponsor**





## Funders <font size="3">^[`r icon::fa_question_circle(size=0.1)`](http://www.spirit-statement.org/funding/)^ </font>



## Roles and responsibilities

### Protocol contributors <font size="3">^[`r icon::fa_question_circle(size=0.1)`](http://www.spirit-statement.org/contributorship/)^ </font>



### Sponsor and funder <font size="3">^[`r icon::fa_question_circle(size=0.1)`](http://www.spirit-statement.org/ssponsor-and-funder/)^ </font>



### Trial committees <font size="3">^[`r icon::fa_question_circle(size=0.1)`](http://www.spirit-statement.org/committees/)^ </font>

N/A



# REFERENCES

# Appendix

## Informed consent materials <font size="3">^[`r icon::fa_question_circle(size=0.1)`](http://www.spirit-statement.org/informed-consent-materials/)^ </font>


## Biological specimens <font size="3">^[`r icon::fa_question_circle(size=0.1)`](http://www.spirit-statement.org/biological-specimens/)^ </font>